The Dementia Trials Accelerator, led by the UK Dementia Research Institute and Health Data Research UK and funded by the ...

Even simple everyday events and actions, such as exercising or driving, cannot be done without accounting for its impact on ...

The World Health Organization’s (WHO) newly published report has placed tuberculosis (TB) as the leading infectious disease killer in 2023, surpassing COVID-19. Newly identified TB cases climbed to ...

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative ...

The 2018 Communications Team of the Year awards are now open for entry, so on p32 we thought we’d ask some top pharma communicators what trends and issues comms teams need to be paying attention to ...

The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has been launched to address the growing skills shortage in the UK’s medicines manufacturing ...

In this issue, we present Alantra’s annual ranking of the 50 fastest-growing, privately owned pharma companies. Of particular note, every single company on this list has delivered annualised revenue ...

As the polls tighten and June’s general election starts to seem very close indeed, we’ve got a roundup of all the major parties’ manifestos and what they would mean for healthcare in the UK. But ...

Do you have a new product, new business focus, or a company to showcase? Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy ...